{"id":2426,"date":"2018-06-04T17:41:31","date_gmt":"2018-06-04T15:41:31","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=2426"},"modified":"2020-10-07T20:00:52","modified_gmt":"2020-10-07T18:00:52","slug":"enyo-pharma-raises-e40-million-in-series-b-fundraising","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/","title":{"rendered":"ENYO Pharma raises \u20ac40 million in Series B fundraising"},"content":{"rendered":"

\"\"<\/p>\n

Lyon, June 4, 2018 \u2013 ENYO Pharma, a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions, today announced that it has completed a \u20ac40 million Series B round of financing from US and European investors. This new funding will enable the company to finance the two first Phase II clinical trial of its EYP001 asset in both chronic HBV and NASH. A second asset is also planned to enter clinic by 2019.<\/p>\n

To read the full press release, click here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Lyon, June 4, 2018 \u2013 ENYO Pharma, a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions, today announced that it has completed a \u20ac40 million Series B round of financing from US and European investors. This new funding will enable the company to finance the two…<\/p>\n","protected":false},"author":5,"featured_media":2421,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[123],"class_list":["post-2426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biodiscovery-en"],"acf":[],"yoast_head":"\nENYO Pharma raises \u20ac40 million in Series B fundraising - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ENYO Pharma raises \u20ac40 million in Series B fundraising - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"Lyon, June 4, 2018 \u2013 ENYO Pharma, a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions, today announced that it has completed a \u20ac40 million Series B round of financing from US and European investors. This new funding will enable the company to finance the two...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-04T15:41:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-07T18:00:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"571\" \/>\n\t<meta property=\"og:image:height\" content=\"326\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stagiaire Communication\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stagiaire Communication\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/\"},\"author\":{\"name\":\"Stagiaire Communication\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8\"},\"headline\":\"ENYO Pharma raises \u20ac40 million in Series B fundraising\",\"datePublished\":\"2018-06-04T15:41:31+00:00\",\"dateModified\":\"2020-10-07T18:00:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/\"},\"wordCount\":92,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg\",\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/\",\"name\":\"ENYO Pharma raises \u20ac40 million in Series B fundraising - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg\",\"datePublished\":\"2018-06-04T15:41:31+00:00\",\"dateModified\":\"2020-10-07T18:00:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg\",\"width\":571,\"height\":326},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anderapartners.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ENYO Pharma raises \u20ac40 million in Series B fundraising\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8\",\"name\":\"Stagiaire Communication\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g\",\"caption\":\"Stagiaire Communication\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ENYO Pharma raises \u20ac40 million in Series B fundraising - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/","og_locale":"en_US","og_type":"article","og_title":"ENYO Pharma raises \u20ac40 million in Series B fundraising - ANDERA PARTNERS","og_description":"Lyon, June 4, 2018 \u2013 ENYO Pharma, a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions, today announced that it has completed a \u20ac40 million Series B round of financing from US and European investors. This new funding will enable the company to finance the two...","og_url":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2018-06-04T15:41:31+00:00","article_modified_time":"2020-10-07T18:00:52+00:00","og_image":[{"width":571,"height":326,"url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg","type":"image\/jpeg"}],"author":"Stagiaire Communication","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Stagiaire Communication"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/"},"author":{"name":"Stagiaire Communication","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8"},"headline":"ENYO Pharma raises \u20ac40 million in Series B fundraising","datePublished":"2018-06-04T15:41:31+00:00","dateModified":"2020-10-07T18:00:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/"},"wordCount":92,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg","articleSection":["andera Life Sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/","url":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/","name":"ENYO Pharma raises \u20ac40 million in Series B fundraising - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg","datePublished":"2018-06-04T15:41:31+00:00","dateModified":"2020-10-07T18:00:52+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#primaryimage","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/06\/ENYO_Pharma.jpg","width":571,"height":326},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/fr\/enyo-pharma-raises-e40-million-in-series-b-fundraising\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anderapartners.com\/en\/"},{"@type":"ListItem","position":2,"name":"ENYO Pharma raises \u20ac40 million in Series B fundraising"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8","name":"Stagiaire Communication","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g","caption":"Stagiaire Communication"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/2426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/comments?post=2426"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/2426\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media\/2421"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media?parent=2426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/categories?post=2426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}